中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2013年
21期
101-102,103
,共3页
心房颤动%血栓栓塞%抗凝治疗
心房顫動%血栓栓塞%抗凝治療
심방전동%혈전전새%항응치료
Atrial fibrillation%Thrombo-embolism%Anticoagulation therapy
目的:了解心房颤动抗凝治疗的现状、影响因素及其与指南推荐的差距。方法:调查2011年1月-2011年6月在本院住院的109例非瓣膜病心房颤动患者的血栓栓塞危险因素、抗凝药物使用情况,采用logistic回归分析法分析影响抗凝治疗的相关因素。结果:具有抗凝指征且无抗凝禁忌证的患者102例,仅12.7%的患者接受华法林治疗,年龄≥75岁、患者对抗凝治疗的选择是影响抗凝治疗的主要因素。结论:本院抗凝治疗的现状与指南推荐差距明显。
目的:瞭解心房顫動抗凝治療的現狀、影響因素及其與指南推薦的差距。方法:調查2011年1月-2011年6月在本院住院的109例非瓣膜病心房顫動患者的血栓栓塞危險因素、抗凝藥物使用情況,採用logistic迴歸分析法分析影響抗凝治療的相關因素。結果:具有抗凝指徵且無抗凝禁忌證的患者102例,僅12.7%的患者接受華法林治療,年齡≥75歲、患者對抗凝治療的選擇是影響抗凝治療的主要因素。結論:本院抗凝治療的現狀與指南推薦差距明顯。
목적:료해심방전동항응치료적현상、영향인소급기여지남추천적차거。방법:조사2011년1월-2011년6월재본원주원적109례비판막병심방전동환자적혈전전새위험인소、항응약물사용정황,채용logistic회귀분석법분석영향항응치료적상관인소。결과:구유항응지정차무항응금기증적환자102례,부12.7%적환자접수화법림치료,년령≥75세、환자대항응치료적선택시영향항응치료적주요인소。결론:본원항응치료적현상여지남추천차거명현。
Objective:To investigate the gap between the present situation and the guideline for anticoagulation therapy in patients with non valvular atrial fibrillation,and analyze the related factors which influence the decision of anticoagulation therapy.Method:Risk factors of thrombo-embolism and usage of anticoagulant were investigated in 109 hospitalized patients with non valvular atrial fibrillation during January 2011 to June 2012, and the related factors which influence the decision of anticoagulation therapy were analyzed using logistic regression analysis.Result:102 patients had anticoagulation indications and no anticoagulation contraindication,only 12.7 percent of patients were treated with warfarin;age ≥ 75 years and the choice of patients were the main factors influencing anticoagulant therapy.Conclusion:There is an obvious gap between the present situation and the guideline for anticoagulation therapy in patients with non valvular atrial fibrillation.